Structure

InChI Key QCGUSIANLFXSGE-GFCCVEGCSA-N
Smile Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](COP(=O)(O)O)OC4=O)cc3F)cn2)n1
InChI
InChI=1S/C17H16FN6O6P/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(30-17(24)25)9-29-31(26,27)28/h2-7,12H,8-9H2,1H3,(H2,26,27,28)/t12-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C17H16FN6O6P
Molecular Weight 450.32
AlogP 1.51
Hydrogen Bond Acceptor 9.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 6.0
Polar Surface Area 152.79
Molecular species ACID
Aromatic Rings 3.0
Heavy Atoms 31.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Bacterial 70S ribosome inhibitor FDA PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pneumonia 3 D011014 ClinicalTrials
Skin Diseases 3 D012871 ClinicalTrials
Infections 3 D007239 ClinicalTrials
Bacterial Infections 3 D001424 ClinicalTrials
Gram-Positive Bacterial Infections 1 D016908 ClinicalTrials
Liver Diseases 1 D008107 ClinicalTrials
Kidney Diseases 1 D007674 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Injury, poisoning and procedural complications
16.31
General disorders and administration site conditions
15.32
Gastrointestinal disorders
14.66
Skin and subcutaneous tissue disorders
8.24
Nervous system disorders
7.58
Infections and infestations
5.77
Investigations
5.77
Cardiac disorders
4.45
Vascular disorders
4.45
Blood and lymphatic system disorders
4.28
Respiratory, thoracic and mediastinal disorders
3.13
Musculoskeletal and connective tissue disorders
2.97
Immune system disorders
2.31

Cross References

Resources Reference
CAS NUMBER 856867-55-5
ChEBI 83326
ChEMBL CHEMBL2105669
DrugBank DB09042
DrugCentral 4873
EPA CompTox DTXSID30234977
FDA SRS O7DRJ6R4DW
PubChem 11476460
SureChEMBL SCHEMBL1557561
ZINC ZINC000043100953